TL
Therapeutic Areas
Grann Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GRN-1 | Obesity, Non-Alcoholic Fatty Liver Disease (NAFLD) | Pre-clinical |
| CA-1 | Colorectal Adenocarcinoma | Pre-clinical |
| GABA-A Variant (GABRA1/GABRG2) | GABA-A Variant Disorders | Pre-clinical |
| RTT1 | Rett Syndrome | Pre-clinical |